2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile

C29H27BrN4O3 — CID 126299149

IUPAC2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile
SMILESCCOc1cc(C)c(-c2nc3ccccc3c(=O)n2N=Cc2ccc(OCC#N)c(Br)c2)cc1C(C)C
InChIInChI=1S/C29H27BrN4O3/c1-5-36-27-14-19(4)23(16-22(27)18(2)3)28-33-25-9-7-6-8-21(25)29(35)34(28)32-17-20-10-11-26(24(30)15-20)37-13-12-31/h6-11,14-18H,5,13H2,1-4H3
InChIKeyGJDUHPVDEHCRMM-UHFFFAOYSA-N
MW559.46 g/mol
LogP6.44
Rot. Bonds8

About 2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile

2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile (PubChem CID 126299149) has the molecular formula C29H27BrN4O3 and a molecular weight of 559.46 g/mol. Its IUPAC name is 2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile.

Molecular Properties

Compound Name2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile
PubChem CID126299149
Molecular FormulaC29H27BrN4O3
Molecular Weight559.46 g/mol
Exact Mass558.13
IUPAC Name2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile
SMILESCCOc1cc(C)c(-c2nc3ccccc3c(=O)n2N=Cc2ccc(OCC#N)c(Br)c2)cc1C(C)C
InChIInChI=1S/C29H27BrN4O3/c1-5-36-27-14-19(4)23(16-22(27)18(2)3)28-33-25-9-7-6-8-21(25)29(35)34(28)32-17-20-10-11-26(24(30)15-20)37-13-12-31/h6-11,14-18H,5,13H2,1-4H3
InChIKeyGJDUHPVDEHCRMM-UHFFFAOYSA-N
XLogP6.44
TPSA89.50 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms37
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500559.46
LogP ≤ 56.44
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze 2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile?
The IUPAC name of 2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile (CID 126299149) is 2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile.
What is the SMILES notation for 2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile?
The canonical SMILES for 2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile is CCOc1cc(C)c(-c2nc3ccccc3c(=O)n2N=Cc2ccc(OCC#N)c(Br)c2)cc1C(C)C.
What is the InChIKey of 2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile?
The InChIKey is GJDUHPVDEHCRMM-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H27BrN4O3/c1-5-36-27-14-19(4)23(16-22(27)18(2)3)28-33-25-9-7-6-8-21(25)29(35)34(28)32-17-20-10-11-26(24(30)15-20)37-13-12-31/h6-11,14-18H,5,13H2,1-4H3.
What are the key properties of 2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile?
2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile has a molecular weight of 559.46 g/mol, XLogP of 6.44, 8 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-bromo-4-[[2-(4-ethoxy-2-methyl-5-propan-2-ylphenyl)-4-oxoquinazolin-3-yl]iminomethyl]phenoxy]acetonitrile is sourced from PubChem (CID 126299149), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).